Novo Nordisk

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments.

CEO

Maziar Mike Doustdar

CEOMaziar Mike Doustdar

Employees

68,794

Employees68,794

Headquarters

Bagsværd, Capital Region

HeadquartersBagsværd, Capital Region

Founded

1923

Founded1923

Employees

68,794

Employees68,794

NVO Key Statistics

Market cap

212.96B

Market cap212.96B

Price-Earnings ratio

11.04

Price-Earnings ratio11.04

Dividend yield

2.61%

Dividend yield2.61%

Average volume

17.26M

Average volume17.26M

High today

$47.84

High today$47.84

Low today

$47.38

Low today$47.38

Open price

$47.44

Open price$47.44

Volume

582.71K

Volume582.71K

52 Week high

$64.16

52 Week high$64.16

52 Week low

$35.12

52 Week low$35.12

NVO News

Nasdaq 2h

NVO Crosses Above Average Analyst Target

In recent trading, shares of Novo-Nordisk AS (Symbol: NVO) have crossed above the average analyst 12-month target price of $47.48, changing hands for $47.73/sha...

The Motley Fool 16h

Why Eli Lilly Topped the Market Today

Eli Lilly (LLY +3.90%) had a fine start to the trading week. On Monday, its stock rose by almost 4% on news that a key European regulator had approved one of it...

TipRanks 22h

Novo Nordisk Expands Treasury Position as 2026 Share Buyback Nears DKK 8 Billion

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

Analyst ratings

54%

of 37 ratings

Buy

37.8%

Hold

54.1%

Sell

8.1%

More NVO News

Nasdaq 4d

Eli Lilly's Timing of the FDA Filing of Its Next Weight-Loss Drug Is Now Official -- and Novo Nordisk Has a Problem

Key Points Eli Lilly should request approval for retatrutide early next year. This medicine could help the company expand the weight loss market. The drugmak...

Simply Wall St 4d

Novo Nordisk Faces A Fair Value Debate, Is It Still 55% Undervalued?

Novo Nordisk (NYSE:NVO) has drawn fresh attention after recent share price moves, with the stock closing at US$45.97. Investors are weighing this level against...

TipRanks 5d

Retail Investors Send in Sick Note for HIMS Stock Ahead of Q2 Earnings

Retail investors are feeling less healthy about the prospects of Hims & Hers (HIMS) as it gets set to report Q2 earnings next week – August 10th. Unlock powerf...

Benzinga 5d

Novo Nordisk Scores Major Court Win, Dutch Judge Halts Compounded Semaglutide Nasal Spray

Dutch judges have issued a preliminary injunction against a European compounding firm, forcing an immediate halt to sales of an unauthorized semaglutide nasal s...

CNBC 5d

The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings

Key Points Both Eli Lilly and Novo Nordisk beat second-quarter estimates and raised their full-year outlooks. But while investors cheered Lilly's results, they...

TipRanks 5d

Novo Nordisk price target raised to $47 from $45 at BMO Capital

BMO Capital analyst Evan Seigerman raised the firm’s price target on Novo Nordisk (NVO) to $47 from $45 and keeps a Market Perform rating on the shares. Novo No...

Seeking Alpha 5d

Amazon delivers GLP-1s for $50 per month for Medicare recipients

Amazon Pharmacy (AMZN) has joined a federal program to offer GLP-1 weight-loss drugs from Novo Nordisk (NVO) and Eli Lilly (LLY) to eligible Medicare enrollees...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.